Bayer Will Donate Chloroquine If Drug Can Treat Virus, CEO Says

The video discusses the company's strong first quarter performance, driven by increased demand during the COVID-19 crisis, and highlights the challenges faced in maintaining operations. It covers shareholder engagement and expectations for the upcoming virtual AGM. The potential use of chloroquine in treating COVID-19 is also discussed, with ongoing clinical trials and plans to donate doses if proven effective.

What feedback has the company received from shareholders regarding its performance?

What is the significance of the upcoming AGM for the company?

What role does chloroquine play in the company's response to COVID-19?